In line with these reports, we found that HCC patients exhibiting lower MAPK10 expression show gene expression profiles consistent with the reduced content of stromal cells and infiltrating immune cells but higher content of tumor cells in the tumor microenvironment compared to patients with higher MAPK10 expression. This evidence concerns the gene MAPK10 and hepatocellular carcinoma.